Lv21
126 积分 2025-01-20 加入
A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index
1天前
求助中
Variants of Toll-like receptor 6 associated with tuberculosis susceptibility in the Chinese Tibetan population
1个月前
已完结
Interleukin-33 and its receptor: multifaceted roles and emerging therapeutic potential
1个月前
已完结
Neuroinflammation and Proinflammatory Cytokines in Epileptogenesis
2个月前
已完结
Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study
2个月前
已完结
A multicentre randomized double-blind placebo-controlled phase III study of the efficacy and safety of xeligekimab (GR1501) in patients with moderate-to-severe plaque psoriasis
3个月前
已完结
Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trial
3个月前
已完结
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
3个月前
已完结
Atopic dermatitis relapse after treatment discontinuation and predictive factors for relapse: JAK1 inhibitors versus dupilumab
3个月前
已完结
Ixekizumab for Active Radiographic Axial Spondyloarthritis in Chinese Patients: 16- and 52-Week Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled Study
3个月前
已完结
皖公网安备34019202002308
